Wolfe Research: 'Bullish long-term on ANAB'
Tweet Send to a Friend
Wolfe Research analyst Andy Chen reiterated an Outperform rating and $25.00 price target on AnaptysBio (NASDAQ: ANAB).The analyst comments "We ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE


